From: A scoping review of indirect comparison methods and applications using individual patient data
Model | 1-stage or 2-stage process | Format of data | Study design | Type of data | Effect size | Assumptions for treatment by covariate interactions |
---|---|---|---|---|---|---|
Donegan et al. [6] | 1-stage | IPD only | RCTs | Dichotomous | Odds ratio | No interactions; exchangeable treatment by covariate interactions; common treatment by covariate interactions |
Donegan et al. [42] | 1-stage | IPD+AD and IPD only | RCTs | Dichotomous | Odds ratio | No interactions; independent treatment by covariate interactions; exchangeable treatment by covariate interactions; common treatment by covariate interactions |
Hong et al. [43] | 1-stage | IPD only | RCTs | Continuous | Mean difference | Exchangeable treatment by covariate interactions |
Jansen [41] | 1-stage | IPD+AD and IPD only | RCTs | Dichotomous | Odds ratio | Exchangeable treatment by covariate interactions; common treatment by covariate interactions |
Saramago et al. [10] | 1-stage | IPD+AD and IPD only | Cluster and individual allocation trials | Dichotomous | Odds ratio | Independent treatment by covariate interactions; exchangeable treatment by covariate interactions; common treatment by covariate interactions |
Saramago et al. [44] | 1-stage | IPD+AD | RCTs | Time-to-event | Hazard ratio | Common treatment by covariate interactions |
Thom et al. [45] | 1-stage | IPD+AD | RCTs and single-arm observational studies | Continuous | Mean difference | Independent treatment by covariate interactions |